Reason, Tim
Rawlinson, William
Langham, Julia http://orcid.org/0000-0003-1046-7598
Gimblett, Andy
Malcolm, Bill
Klijn, Sven http://orcid.org/0000-0002-1556-8382
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Accepted: 1 February 2024
First Online: 10 February 2024
Declarations
:
: This study was funded by Bristol Myers Squibb. The study sponsor was involved in several aspects of the research, including the study design, interpretation of data, writing of the manuscript and decision to submit the manuscript for publication.
: This study was supported by Bristol Myers Squibb. Estima authors (Tim Reason, William Rawlinson, Julia Langham, Andy Gimblett) are consultants and have worked on behalf of Bill Malcolm and Sven Klijn, who are employees and shareholders of Bristol Myers Squibb.
: All data generated or analysed during this study are included in this published article (and its supplementary information files).
: No human participants, their data or biological material were used in this study.
: This article does not contain identifiable photos or patient data.
: No human participants took part in this study.
: All AI-generated R code has been provided in the Online Resource, in addition to the prompts that were used to describe the designs and inputs of each replicated model, and the user-defined R functions that were used by GPT-4.
: All authors (TR, WR, JL, AG, BM and SK) contributed to the study conception and design. Material preparation, data collection and analysis were performed by TR and WR. The first draft of the manuscript was written by WR and all authors (TR, WR, JL, AG, BM and SK) commented on previous versions of the manuscript. All authors (TR, WR, JL, AG, BM and SK) read and approved the final manuscript.